Market Overview:
The global gut-on-a-chip market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for organ-on-chip technology from pharmaceutical companies, hospitals and clinics, academic and government research institutes, and biotechnology companies. The North American region is expected to dominate the global gut-on-a chip market during the forecast period.
Product Definition:
Gut-on-a-Chip is a microfluidic device that cultured human intestinal cells on a chip to mimic the function of the gut. Gut-on-a-Chip can be used to study gut diseases and test drugs and supplements.
Heart-on-chip:
The heart-on-a-chip is a microelectronic device that integrates the functions of a miniature electric circuit with the functionality of an organ. It is used for research and development in areas such as personalized medicine, biomarker discovery, drug screening, and patient monitoring. The technology has been around for more than two decades but has only recently started to make inroads into conventional chip design practices.
Human-on-chip:
The human-on-chip (HOC) is a technology that enables the integration of microchips with living tissues to be used in medical devices. The technology was developed by researchers at Massachusetts Institute of Technology's Media Lab and Wyss Institute for Biologically Inspired Engineering at Harvard University. HOCs are also known as microchips with organs on them or organ chips.
Application Insights:
The pharmaceutical companies segment dominated the global gut-on-a-chip market in terms of revenue share in 2017. The application of gut on a chip for drug development and testing is anticipated to improve significantly over the coming years. Moreover, miniaturization of this technology for testing drugs is expected to reduce the costs associated with animal tests and facilitate faster drug approvals. These factors are likely to contribute towards industry growth during the forecast period.
The hospitals and clinics segment was valued at USD 120 million in 2017 owing to increasing incidence of chronic diseases such as diabetes, obesity, cardiovascular diseases among others which points towards a need for advanced healthcare delivery systems that can help patients better manage their health conditions thereby contributing towards industry growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to various factors such as favorable government initiatives, increasing investments by private companies, and collaborations between academic institutions and industry players. For instance, in May 2018, researchers from the University of Pennsylvania collaborated with UPM Biomedicals to develop a miniaturized 3D human model for testing drug efficacy using microfluidic chips developed through UPM's GOCart platform. The research was published online in Lab on Chip journal (2018).
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to several ongoing projects within this region that aim at developing novel technologies for use in biomedical research. In November 2016, researchers from Singapore developed an artificial intelligence-based system known as Smart Fluidic chip technology that can screen drugs against cancerous cells without any need of cell cultures or animal models (Saravanan et al., 2016).
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of gut-related diseases
- Advances in Gut-on-a-Chip technology
- Growing investment in gut research
- Increasing focus on precision medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Gut-on-a-Chip Market Research Report
By Type
Heart-on-chip, Human-on-chip, Intestine-on-chip, Kidney-on-chip, Liver-on-chip, Lung-on-chip
By Application
Pharmaceutical Companies, Hospitals and Clinics, Academic and Government Research Institutes, Biotechnology Companies
By Companies
Emulate, Inc., AxoSim Technologies LLC, CN Bio Innovations, Hurel Corporation, Ascendance Biotechnology, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc., Tara Biosystems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Gut-on-a-Chip Market Report Segments:
The global Gut-on-a-Chip market is segmented on the basis of:
Types
Heart-on-chip, Human-on-chip, Intestine-on-chip, Kidney-on-chip, Liver-on-chip, Lung-on-chip
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Hospitals and Clinics, Academic and Government Research Institutes, Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Emulate, Inc.
- AxoSim Technologies LLC
- CN Bio Innovations
- Hurel Corporation
- Ascendance Biotechnology, Inc.
- Insphero AG
- Mimetas B.V.
- Nortis Inc.
- Organovo Holdings, Inc.
- Tara Biosystems
Highlights of The Gut-on-a-Chip Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Heart-on-chip
- Human-on-chip
- Intestine-on-chip
- Kidney-on-chip
- Liver-on-chip
- Lung-on-chip
- By Application:
- Pharmaceutical Companies
- Hospitals and Clinics
- Academic and Government Research Institutes
- Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gut-on-a-Chip Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gut-on-a-Chip is a technology that allows for the miniaturization of gut microbiota. Gut microbiota are the trillions of bacteria and other microorganisms that live in our intestines.
Some of the key players operating in the gut-on-a-chip market are Emulate, Inc., AxoSim Technologies LLC, CN Bio Innovations, Hurel Corporation, Ascendance Biotechnology, Inc., Insphero AG, Mimetas B.V., Nortis Inc., Organovo Holdings, Inc., Tara Biosystems.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gut-on-a-Chip Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gut-on-a-Chip Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gut-on-a-Chip Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gut-on-a-Chip Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gut-on-a-Chip Market Size & Forecast, 2018-2028
4.5.1 Gut-on-a-Chip Market Size and Y-o-Y Growth
4.5.2 Gut-on-a-Chip Market Absolute $ Opportunity
Chapter 5 Global Gut-on-a-Chip Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gut-on-a-Chip Market Size Forecast by Type
5.2.1 Heart-on-chip
5.2.2 Human-on-chip
5.2.3 Intestine-on-chip
5.2.4 Kidney-on-chip
5.2.5 Liver-on-chip
5.2.6 Lung-on-chip
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gut-on-a-Chip Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gut-on-a-Chip Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Hospitals and Clinics
6.2.3 Academic and Government Research Institutes
6.2.4 Biotechnology Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gut-on-a-Chip Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gut-on-a-Chip Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gut-on-a-Chip Analysis and Forecast
9.1 Introduction
9.2 North America Gut-on-a-Chip Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gut-on-a-Chip Market Size Forecast by Type
9.6.1 Heart-on-chip
9.6.2 Human-on-chip
9.6.3 Intestine-on-chip
9.6.4 Kidney-on-chip
9.6.5 Liver-on-chip
9.6.6 Lung-on-chip
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gut-on-a-Chip Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Hospitals and Clinics
9.10.3 Academic and Government Research Institutes
9.10.4 Biotechnology Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gut-on-a-Chip Analysis and Forecast
10.1 Introduction
10.2 Europe Gut-on-a-Chip Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gut-on-a-Chip Market Size Forecast by Type
10.6.1 Heart-on-chip
10.6.2 Human-on-chip
10.6.3 Intestine-on-chip
10.6.4 Kidney-on-chip
10.6.5 Liver-on-chip
10.6.6 Lung-on-chip
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gut-on-a-Chip Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Hospitals and Clinics
10.10.3 Academic and Government Research Institutes
10.10.4 Biotechnology Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gut-on-a-Chip Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gut-on-a-Chip Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gut-on-a-Chip Market Size Forecast by Type
11.6.1 Heart-on-chip
11.6.2 Human-on-chip
11.6.3 Intestine-on-chip
11.6.4 Kidney-on-chip
11.6.5 Liver-on-chip
11.6.6 Lung-on-chip
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gut-on-a-Chip Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Hospitals and Clinics
11.10.3 Academic and Government Research Institutes
11.10.4 Biotechnology Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gut-on-a-Chip Analysis and Forecast
12.1 Introduction
12.2 Latin America Gut-on-a-Chip Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gut-on-a-Chip Market Size Forecast by Type
12.6.1 Heart-on-chip
12.6.2 Human-on-chip
12.6.3 Intestine-on-chip
12.6.4 Kidney-on-chip
12.6.5 Liver-on-chip
12.6.6 Lung-on-chip
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gut-on-a-Chip Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Hospitals and Clinics
12.10.3 Academic and Government Research Institutes
12.10.4 Biotechnology Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gut-on-a-Chip Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gut-on-a-Chip Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gut-on-a-Chip Market Size Forecast by Type
13.6.1 Heart-on-chip
13.6.2 Human-on-chip
13.6.3 Intestine-on-chip
13.6.4 Kidney-on-chip
13.6.5 Liver-on-chip
13.6.6 Lung-on-chip
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gut-on-a-Chip Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Hospitals and Clinics
13.10.3 Academic and Government Research Institutes
13.10.4 Biotechnology Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gut-on-a-Chip Market: Competitive Dashboard
14.2 Global Gut-on-a-Chip Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Emulate, Inc.
14.3.2 AxoSim Technologies LLC
14.3.3 CN Bio Innovations
14.3.4 Hurel Corporation
14.3.5 Ascendance Biotechnology, Inc.
14.3.6 Insphero AG
14.3.7 Mimetas B.V.
14.3.8 Nortis Inc.
14.3.9 Organovo Holdings, Inc.
14.3.10 Tara Biosystems
